| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |